Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral isotretinoin with fractional radiofrequency microneedling vs low-dose oral isotretinoin alone in moderate to severe acne vulgaris
TCTR20250202008Phase 2Completed
- Sponsor
- Thammasat University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isotretinoin in acne vulgaris, sponsored by Thammasat University. Started Aug 2023; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20250202008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250202008.